About Aerogen
Aerogen is a company based in Galway (Ireland) founded in 1997 by John Power was acquired by Nektar in August 2005. Aerogen has raised $18 million across 4 funding rounds from investors including J P Morgan, Temasek and European Union. Aerogen offers products and services including Aerogen Solo and Aerogen Ultra.
- Headquarter Galway, Ireland
- Founders John Power
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aerogen Medical Devices India Private Limited
- Date of Incorporation 17 Dec, 2019
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$868.76 K (USD)1252.22as on Mar 31, 2022
-
Net Profit
-$261.95 K (USD)-285.32as on Mar 31, 2022
-
EBITDA
-$282.14 K (USD)-71.7as on Mar 31, 2022
-
Total Equity Funding
$18 M (USD)
in 4 rounds
-
Latest Funding Round
$94.83 K (USD), Grant
Jun 01, 2022
-
Investors
J P Morgan
& 7 more
-
Employee Count
Not available
-
Acquired by
Nektar
(Aug 15, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aerogen
Aerogen offers a comprehensive portfolio of products and services, including Aerogen Solo and Aerogen Ultra.
Aerogen Solo is employed as a single-patient-use device that facilitates aerosol drug delivery across stages of respiratory therapy, including invasive and non-invasive ventilation.
Aerogen Ultra is utilized as a handheld device in conjunction with other products to support inhalation treatments during respiratory exacerbations or post-ventilation scenarios.
People of Aerogen
Unlock access to complete
Unlock access to complete
Funding Insights of Aerogen
Aerogen has successfully raised a total of $18M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $94.83 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aerogen
Aerogen has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Temasek and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked | |
|
Early-stage investing in IT and healthcare ventures.
|
Locked | Locked | Locked | |
|
Tech-based companies are invested in by Wheatley Partners.
|
Locked | Locked | Locked |
Investor details for Aerogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aerogen
Investment portfolio details for Aerogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aerogen
Detailed financials for Aerogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aerogen Comparisons
Peer comparison for Aerogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aerogen
Detailed competitors of Aerogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aerogen
Complete news archive for Aerogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aerogen
Aerogen was founded in 1997 and raised its 1st funding round 1 year after it was founded.
Aerogen is headquartered in Galway, Ireland.
John Power is the current CEO of Aerogen. They have also founded this company.
Aerogen is a funded company, having raised a total of $18M across 4 funding rounds to date.
Annual revenue of Aerogen is $868.76K as on Mar 31, 2022.
Aerogen was established in 1997 in Galway, Ireland, within the medical devices sector. Vibrating mesh nebulizers are produced for aerosol drug delivery in respiratory therapy applications. These devices support invasive and non-invasive mechanical ventilation, high-flow systems, and self-ventilating methods. Single-patient-use options, handheld units, controllers, and accessories are offered for compatibility with various respiratory equipment.
Aerogen offers Aerogen Solo and Aerogen Ultra.
Aerogen has 8 investors. Key investors include J P Morgan, Temasek, European Union, Invesco Mutual Fund, and Nektar.